Body’s ageing process accelerated by DNA changes, study suggests
Published: 2 September 2019
DNA changes throughout a person’s life can significantly increase susceptibility to heart conditions and other age-related disease
DNA changes throughout a person’s life can significantly increase their susceptibility to heart conditions and other age-related diseases, research suggests.
Such alterations – known as somatic mutations – can impact the way blood stem cells work and are associated with blood cancers and other conditions.
A study says that these somatic mutations and the associated diseases they cause may accelerate a person’s biological age – how old their body appears – faster than their chronological age – the number of years they have been alive.
A study by scientists from the Universities of Edinburgh and Glasgow examined these changes and their potential effects in more than 1000 older people from the Lothian Birth Cohorts (LBCs), born in 1921 and 1936.
The LBCs are a group of people – now in their 80s and 90s – who sat intelligence tests as 11-year olds. They are some of the most-intensively studied research participants in the world.
Scientists studied people where the biological and chronological age was separated by a large gap.
They found the participants with somatic mutations – around six per cent – had a biological age almost four years older than those with no alterations.
Experts say they will now explore the link between these DNA changes and biological ageing acceleration.
The study, published in Current Biology, was funded by Alzheimer's Research UK.
Dr Kristina Kirschner, an expert in haematology from the University of Glasgow, said: “Given that mutations in blood stem cells can lead to other disease such as cardiovascular disease we now need to find out how the two are related.”
Dr Tamir Chandra, Group Leader at the University of Edinburgh’s MRC Human Genetics Unit, said: “Previously, somatic mutations have largely been studied in cancer. Our findings suggest they play a role in other diseases, which will change the way we study disease risk.”
Enquiries: ali.howard@glasgow.ac.uk orelizabeth.mcmeekin@glasgow.ac.uk / 0141 330 6557 or 0141 330 4831
First published: 2 September 2019
<< September
Related Links
- Dr Kristina Kirschner, research profile
- Institute of Cancer Sciences
- College of Medical, Veterinary and Life Sciences
- Link to the study in Currrent Biology
- Alzheimer's Research UK